{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T20:11:57Z","timestamp":1784146317888,"version":"3.55.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":158,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","award":["BRC-1215-20014"],"award-info":[{"award-number":["BRC-1215-20014"]}],"id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.neulet.2021.136289","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T17:48:00Z","timestamp":1633974480000},"page":"136289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Reduced expression of dopamine D2 receptors on astrocytes in R6\/1 HD mice and HD post-mortem tissue"],"prefix":"10.1016","volume":"767","author":[{"given":"Kate L.","family":"Harris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Vallin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger A.","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neulet.2021.136289_b0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1471-4159.1992.tb09283.x","article-title":"Increased cerebrospinal fluid dopamine and 3,4-dihydroxyphenylacetic acid levels in Huntington\u2019s disease: evidence for an overactive dopaminergic brain transmission","volume":"58","author":"Garrett","year":"1992","journal-title":"J. Neurochem."},{"issue":"40","key":"10.1016\/j.neulet.2021.136289_b0010","doi-asserted-by":"crossref","first-page":"10090","DOI":"10.1523\/JNEUROSCI.3237-08.2008","article-title":"Dopaminergic and glutamatergic signaling crosstalk in Huntington's disease neurodegeneration: the role of p25\/cyclin-dependent kinase 5","volume":"28","author":"Paoletti","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2021.136289_b0015","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0502698102","article-title":"Unraveling a role for dopamine in Huntington\u2019s disease: the dual role of reactive oxygen species and D2 receptor stimulation","author":"Charvin","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"issue":"4","key":"10.1016\/j.neulet.2021.136289_b0020","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1523\/JNEUROSCI.3539-10.2011","article-title":"Differential electrophysiological changes in striatal output neurons in Huntington\u2019s disease","volume":"31","author":"Andre","year":"2011","journal-title":"J. Neurosci."},{"issue":"Pt 3","key":"10.1016\/j.neulet.2021.136289_b0025","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/brain\/120.3.503","article-title":"PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington\u2019s disease","volume":"120","author":"Ginovart","year":"1997","journal-title":"Brain: A J. Neurol."},{"issue":"3","key":"10.1016\/j.neulet.2021.136289_b0030","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/brain\/118.3.689","article-title":"Striatal D1 and D2 receptor binding in patients with Huntington's disease and other choreas A PET study","volume":"118","author":"Turjanski","year":"1995","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.neulet.2021.136289_b0035","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/brain\/122.12.2353","article-title":"Huntington\u2019s disease progression: PET and clinical observations","volume":"122","author":"Andrews","year":"1999","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.neulet.2021.136289_b0040","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1468-1331.2008.02390.x","article-title":"Changes in striatal dopamine D2 receptor binding in pre-clinical Huntington\u2019s disease","volume":"16","author":"van Oostrom","year":"2009","journal-title":"Eur. J. Neurol."},{"issue":"6","key":"10.1016\/j.neulet.2021.136289_b0045","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1093\/brain\/119.6.2085","article-title":"Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease","volume":"119","author":"Antonini","year":"1996","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neulet.2021.136289_b0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ana.410400110","article-title":"Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease","volume":"40","author":"Weeks","year":"1996","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.neulet.2021.136289_b0055","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/syn.890020511","article-title":"Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington\u2019s disease and schizophrenia","volume":"2","author":"Joyce","year":"1988","journal-title":"Synapse"},{"issue":"5","key":"10.1016\/j.neulet.2021.136289_b0060","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/brain\/awg119","article-title":"Progressive striatal and cortical dopamine receptor dysfunction in Huntington\u2019s disease: a PET study","volume":"126","author":"Pavese","year":"2003","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.neulet.2021.136289_b0065","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1093\/brain\/120.12.2207","article-title":"Cognitive deficits in Huntington\u2019s disease are predicted by dopaminergic PET markers and brain volumes","volume":"120","author":"Backman","year":"1997","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.neulet.2021.136289_b0070","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1093\/brain\/120.12.2207","article-title":"Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes","volume":"120","author":"B\u00e4ckman","year":"1997","journal-title":"Brain: A J. Neurol."},{"issue":"2","key":"10.1016\/j.neulet.2021.136289_b0075","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.nbd.2009.10.015","article-title":"Cortical dopamine dysfunction in symptomatic and premanifest Huntington\u2019s disease gene carriers","volume":"37","author":"Pavese","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.neulet.2021.136289_b0080","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/jnr.10272","article-title":"Striatal neurochemical changes in transgenic models of Huntington\u2019s disease","volume":"68","author":"Ariano","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neulet.2021.136289_b0085","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.120166397","article-title":"Severe deficiencies in dopamine signaling in presymptomatic Huntington\u2019s disease mice","author":"Bibb","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neulet.2021.136289_b0090","article-title":"Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene","author":"Cha","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neulet.2021.136289_b0095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.nbd.2014.02.004","article-title":"Dopaminergic manipulations and its effects on neurogenesis and motor function in a transgenic mouse model of Huntington\u2019s disease","volume":"66","author":"Choi","year":"2014","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.neulet.2021.136289_b0100","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0169-328X(94)90227-5","article-title":"Evidence for dopamine D2 receptor mRNA expression by striatal astrocytes in culture: in situ hybridization and polymerase chain reaction studies","volume":"23","author":"Bal","year":"1994","journal-title":"Mol. Brain Res."},{"issue":"4","key":"10.1016\/j.neulet.2021.136289_b0105","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/(SICI)1097-4547(19991115)58:4<544::AID-JNR7>3.0.CO;2-9","article-title":"Pharmacological and molecular evidence for dopamine D1 receptor expression by striatal astrocytes in culture","volume":"58","author":"Zanassi","year":"1999","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.neulet.2021.136289_b0110","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.brainres.2004.09.014","article-title":"Direct evidence for expression of dopamine receptors in astrocytes from basal ganglia","volume":"1029","author":"Miyazaki","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2021.136289_b0115","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3389\/fnagi.2017.00410","article-title":"Metabolism of dopamine in nucleus accumbens astrocytes is preserved in aged mice exposed to MPTP","volume":"9","author":"Winner","year":"2017","journal-title":"Front. Aging Neurosci."},{"issue":"4","key":"10.1016\/j.neulet.2021.136289_b0120","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41380-018-0226-y","article-title":"Dysfunction of homeostatic control of dopamine by astrocytes in the developing prefrontal cortex leads to cognitive impairments","volume":"25","author":"Petrelli","year":"2020","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.neulet.2021.136289_b0125","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41386-018-0151-4","article-title":"Ventral midbrain astrocytes display unique physiological features and sensitivity to dopamine D2 receptor signaling","volume":"44","author":"Xin","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neulet.2021.136289_b0130","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-019-1652-8","article-title":"Dopamine receptor D3 signalling in astrocytes promotes neuroinflammation","volume":"16","author":"Montoya","year":"2019","journal-title":"J. Neuroinflamm."},{"issue":"7435","key":"10.1016\/j.neulet.2021.136289_b0135","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature11748","article-title":"Suppression of neuroinflammation by astrocytic dopamine D2 receptors via \u03b1B-crystallin","volume":"494","author":"Shao","year":"2013","journal-title":"Nature"},{"issue":"1-2","key":"10.1016\/j.neulet.2021.136289_b0140","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jns.2010.01.013","article-title":"The effect of dopamine agonists: The expression of GDNF, NGF, and BDNF in cultured mouse astrocytes","volume":"291","author":"Ohta","year":"2010","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.neulet.2021.136289_b0145","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/glia.23103","article-title":"Dopamine elevates and lowers astroglial Ca2+ through distinct pathways depending on local synaptic circuitry","volume":"65","author":"Jennings","year":"2017","journal-title":"GLIA."},{"issue":"6","key":"10.1016\/j.neulet.2021.136289_b0150","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.neuron.2019.12.026","article-title":"Dopamine-evoked synaptic regulation in the nucleus accumbens requires astrocyte activity","volume":"105","author":"Corkrum","year":"2020","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.neulet.2021.136289_b0155","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.tins.2017.05.002","article-title":"Unravelling and exploiting astrocyte dysfunction in Huntington\u2019s disease","volume":"40","author":"Khakh","year":"2017","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neulet.2021.136289_b0160","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/10.2.137","article-title":"Neurological abnormalities in a knock-in mouse model of Huntington\u2019s disease","author":"Lin","year":"2001","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.neulet.2021.136289_b0165","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-020-0880-6","article-title":"Single-nucleus RNA-seq identifies Huntington disease astrocyte states","volume":"8","author":"Al-Dalahmah","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"issue":"7","key":"10.1016\/j.neulet.2021.136289_b0170","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.celrep.2018.04.052","article-title":"Integrative characterization of the R6\/2 mouse model of Huntington\u2019s disease reveals dysfunctional astrocyte metabolism","volume":"23","author":"Skotte","year":"2018","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.neulet.2021.136289_b0175","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11758","article-title":"Human glia can both induce and rescue aspects of disease phenotype in Huntington disease","volume":"7","author":"Benraiss","year":"2016","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.neulet.2021.136289_b0180","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.stem.2018.11.010","article-title":"Human ESC-derived chimeric mouse models of Huntington\u2019s disease reveal cell-intrinsic defects in glial progenitor cell differentiation","volume":"24","author":"Osipovitch","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.neulet.2021.136289_b0185","doi-asserted-by":"crossref","DOI":"10.1038\/nn.3691","article-title":"Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington\u2019s disease model mice","author":"Tong","year":"2014","journal-title":"Nat. Neurosci."},{"issue":"5","key":"10.1016\/j.neulet.2021.136289_b0190","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1006\/nbdi.2001.0430","article-title":"Impaired glutamate uptake in the R6 Huntington\u2019s disease transgenic mice","volume":"8","author":"Li\u00e9vens","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2021.136289_b0195","doi-asserted-by":"crossref","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of huntington\u2019s disease","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"6","key":"10.1016\/j.neulet.2021.136289_b0200","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1369\/0022155414531549","article-title":"Characterizing and diminishing autofluorescence in formalin-fixed paraffin-embedded human respiratory tissue","volume":"62","author":"Davis","year":"2014","journal-title":"J. Histochem. Cytochem."},{"issue":"3","key":"10.1016\/j.neulet.2021.136289_b0205","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/neup.12273","article-title":"Applicability of digital analysis and imaging technology in neuropathology assessment","volume":"36","author":"Dunn","year":"2016","journal-title":"Neuropathology"},{"issue":"9","key":"10.1016\/j.neulet.2021.136289_b0210","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1136\/jnnp-2015-312413","article-title":"Hippocampal dysfunction defines disease onset in Huntington\u2019s disease","volume":"87","author":"Begeti","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neulet.2021.136289_b0215","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cortex.2019.07.014","article-title":"Huntington's disease patients display progressive deficits in hippocampal-dependent cognition during a task of spatial memory","volume":"119","author":"Harris","year":"2019","journal-title":"Cortex"},{"issue":"13","key":"10.1016\/j.neulet.2021.136289_b0220","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1523\/JNEUROSCI.20-13-05115.2000","article-title":"Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington\u2019s disease mutation","volume":"20","author":"Murphy","year":"2000","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neulet.2021.136289_b0225","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0006-8993(76)90057-3","article-title":"Regional concentrations of noradrenaline and dopamine in rat brain","volume":"113","author":"Versteeg","year":"1976","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.neulet.2021.136289_b0230","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2478\/v10134-010-0035-6","article-title":"Astrocyte expression of D2-like dopamine receptors in the prefrontal cortex","volume":"1","author":"Mladinov","year":"2010","journal-title":"Transl. Neurosci."},{"key":"10.1016\/j.neulet.2021.136289_b0235","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/B978-0-444-63425-2.00010-6","article-title":"The role of dopamine in Huntington's disease","volume":"211","author":"Cepeda","year":"2014","journal-title":"Prog. Brain Res."},{"issue":"6","key":"10.1016\/j.neulet.2021.136289_b0240","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020628","article-title":"Astrocytes in neurodegenerative disease","volume":"7","author":"Phatnani","year":"2015","journal-title":"Cold Spring Harbor. Perspect. Biol."},{"issue":"2","key":"10.1016\/j.neulet.2021.136289_b0245","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0304-3940(91)90583-F","article-title":"Neuronal loss in layers V and VI of cerebral cortex in Huntington\u2019s disease","volume":"133","author":"Hedreen","year":"1991","journal-title":"Neurosci. Lett."},{"issue":"15","key":"10.1016\/j.neulet.2021.136289_b0250","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1093\/hmg\/ddq212","article-title":"In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington\u2019s disease subjects","volume":"19","author":"Faideau","year":"2010","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.neulet.2021.136289_b0255","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0006-8993(90)91578-5","article-title":"Dopaminergic antagonists prevent long-term maintenance of posttetanic LTP in the CA1 region of rat hippocampal slices","volume":"522","author":"Frey","year":"1990","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.neulet.2021.136289_b0260","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bbr.2011.03.069","article-title":"Impairments of exploration and memory after systemic or prelimbic D1-receptor antagonism in rats","volume":"223","author":"Clausen","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"6","key":"10.1016\/j.neulet.2021.136289_b0265","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.biopsych.2014.03.013","article-title":"Presynaptic D2 dopamine receptors control long-term depression expression and memory processes in the temporal hippocampus","volume":"77","author":"Rocchetti","year":"2015","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.neulet.2021.136289_b0270","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neulet.2007.06.012","article-title":"Morris water maze learning in Long-Evans rats is differentially affected by blockade of D1-like and D2-like dopamine receptors","volume":"422","author":"Stuchlik","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2021.136289_b0275","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2014.04.023","article-title":"Hippocampal place cell responses to distal and proximal cue manipulations in dopamine D2 receptor-knockout mice","volume":"1567","author":"Nguyen","year":"2014","journal-title":"Brain Res."},{"issue":"50","key":"10.1016\/j.neulet.2021.136289_b0280","doi-asserted-by":"crossref","first-page":"13390","DOI":"10.1523\/JNEUROSCI.2680-08.2008","article-title":"Dopamine D1 receptor modulates hippocampal representation plasticity to spatial novelty","volume":"28","author":"Tran","year":"2008","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neulet.2021.136289_b0285","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0006-8993(94)90263-1","article-title":"Tonic D2-mediated attenuation of cortical excitation in nucleus accumbens neurons recorded in vitro","volume":"634","author":"O'Donnell","year":"1994","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.neulet.2021.136289_b0290","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0896-6273(02)00859-0","article-title":"A D2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission","volume":"35","author":"Kotecha","year":"2002","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.neulet.2021.136289_b0295","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000477313","article-title":"Antipsychotic-induced dopamine supersensitivity psychosis: pharmacology, criteria, and therapy","volume":"86","author":"Chouinard","year":"2017","journal-title":"Psychother. Psychosom."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394021006686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394021006686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:40:21Z","timestamp":1759624821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394021006686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":59,"alternative-id":["S0304394021006686"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2021.136289","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced expression of dopamine D2 receptors on astrocytes in R6\/1 HD mice and HD post-mortem tissue","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2021.136289","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 MRC Laboratory of Molecular Biology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"136289"}}